TL Biopharmaceutical - Biosimilar Drugs' Unit Acquisition

TL Biopharmaceutical - Biosimilar Drugs raised a round of funding on February 10, 2017. Investors include Aurobindo Pharma.

TL Biopharmaceutical is a Swiss firm that specializes in biosimilar products.…

Articles about TL Biopharmaceutical - Biosimilar Drugs' Unit Acquisition: